Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
07/2011
07/13/2011CN102119938A Folk Chinese herb medicine fruiting eight trigram-shaped maple root wine
07/13/2011CN102119929A Medicinal composition of sulbenicillin sodium for injection and preparation method thereof
07/13/2011CN102119924A Monodisperse nano aztreonam liposome preparation and preparation method thereof
07/13/2011CN102119923A Antibiotic oil-water double suspension type injection emulsion for livestock and preparation method thereof
07/13/2011CN102119921A Aivlosin injection for swine and preparation method thereof
07/13/2011CN102119919A Preparation method of valnemulin oily injection
07/13/2011CN101721378B Method for preparing cefmenoxime hydrochloride freeze-dried powder injection
07/13/2011CN101716142B Nimesulide injection for livestock and preparation method thereof
07/13/2011CN101648929B Lignanoid-like compound contained in cabo and preparation method and application thereof
07/13/2011CN101584702B Method of preparing extract of Mallotus apelta and uses for fighting hepatitis B virus
07/13/2011CN101531637B A novel compound capable of restraining and blocking M2 ion channel activity and application thereof
07/13/2011CN101518644B Application of Ang-2 and genes thereof in pharmacy
07/13/2011CN101440098B Crystal of oxacephem
07/13/2011CN101342229B Composition of Canton love-pea vine extract, preparation method and pharmaceutical use
07/13/2011CN101306126B Quality control method of compound south isatis root granules
07/13/2011CN101220002B Oxazolidinone compound as antimicrobial
07/12/2011US7977477 Benzimidazole derivatives and their use as protein kinase inhibitors
07/12/2011US7977349 Substituted quinolones III
07/12/2011US7977330 Salts and crystal modifications thereof
07/12/2011US7977327 Substituted pyrrolidine derivative
07/12/2011US7977047 Delete sequence in M. tuberculosis, method for detecting mycobacteria using these sequences and vaccines
07/12/2011US7976870 using a sustained release oral dosage form of a therapeutically effective amount of the drug such as minocycline hydrochloride incorporated in a matrix of biocompatible, hydrophilic polymer of specified swelling properties and erosion rate
07/12/2011US7976849 Hepatitis-C virus testing
07/12/2011US7976846 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor
07/12/2011US7976844 Fusion proteins of Mycobacterium tuberculosis
07/12/2011US7976843 Method for screening peptides for use in immunotherapy
07/12/2011CA2588398C Potassium salt of an hiv integrase inhibitor
07/12/2011CA2517629C Phthalazinone derivatives
07/12/2011CA2516699C Hiv replication inhibiting pyrimidines and triazines
07/12/2011CA2497167C Modified saccharides, conjugates thereof, and their manufacture
07/12/2011CA2481767C Severe sepsis preventive therapeutic agent
07/12/2011CA2480162C Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
07/12/2011CA2463616C Affinity enhancement agents
07/12/2011CA2463505C Low-calcemic oxime analogs of 1.alpha.,25-dihydroxy vitamin d3
07/12/2011CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide
07/12/2011CA2457528C Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina)
07/12/2011CA2449150C Tricyclic compounds useful as angiotensin ii agonists
07/12/2011CA2435611C Alpha-amino-n-hydroxy-acetamide derivatives
07/12/2011CA2419148C Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
07/12/2011CA2405438C Hepatitis b core antigen fusion proteins
07/12/2011CA2397347C Factor vii or viia-like molecules
07/12/2011CA2393312C Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha.
07/12/2011CA2389685C Novel heterocyclic compounds and their use as medicaments
07/12/2011CA2351712C Crystal modification a of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
07/12/2011CA2341336C Elongase genes and uses thereof
07/12/2011CA2329133C Recombinant venezuelan equine encephalitis virus vaccine
07/12/2011CA2182976C Active immunization using a siderophore receptor protein
07/07/2011WO2011082422A2 Human immunodeficiency virus (hiv-1) highly conserved and low variant sequences as targets for vaccine and diagnostic applications
07/07/2011WO2011082400A2 Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
07/07/2011WO2011082331A2 Compositions and methods for treating hepatitis b virus infection
07/07/2011WO2011082289A1 Cyclosporine analogues
07/07/2011WO2011082077A1 Hepatitis c virus inhibitors
07/07/2011WO2011081765A1 Pythium immunotherapy
07/07/2011WO2011081612A1 Use of krypton or xenon as an antiviral agent
07/07/2011WO2011081523A1 Interferon analogs
07/07/2011WO2011081173A1 Tetracyclic compound
07/07/2011WO2011081083A1 Neuraminic acid derivative, sialidase activity inhibitor and antiinfluenza drug
07/07/2011WO2011080691A1 Method for the production of amorphous rifaximin
07/07/2011WO2011080562A1 Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals
07/07/2011WO2011080266A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives.
07/07/2011WO2011080265A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
07/07/2011WO2011080264A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof
07/07/2011WO2011080259A1 Lipopeptide- and lipoprotein-conjugates and its use
07/07/2011WO2011079969A1 A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative
07/07/2011WO2011079627A1 Multi-component adjuvant of immersion vaccine for fish, and its application and using method
07/07/2011WO2011079501A1 Prodrug based on cytarabine structure as well as synthesizing method and application thereof
07/07/2011WO2011079349A1 Okadaella gastrococcus and cancer
07/07/2011WO2011008092A4 Gram-positive bacteria specific binding compounds
07/07/2011WO2011005044A9 Novel strain of streptomyces sporoclivatus which suppresses ginseng root rot
07/07/2011WO2010091373A8 Trimeric hiv fusion inhibitors for treating or preventing hiv infection
07/07/2011WO2010057275A8 Cyclic peptides and uses thereof
07/07/2011US20110167512 Hybrid artichoke variety nun 4006 ar
07/07/2011US20110166320 Somatostatin analogues
07/07/2011US20110166218 Methods for micronization of hydrophobic drugs
07/07/2011US20110166207 Use of aav integration efficiency element for mediating site-specific integration of a transcription unit
07/07/2011US20110166179 Antibacterial quinoline derivatives
07/07/2011US20110166175 7-azaindole derivatives
07/07/2011US20110166173 3,5-disubstututed 1h-pyrrolo [2,3-b] pyridines as jnk inhibitors
07/07/2011US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof
07/07/2011US20110166164 THIAZOLO[5,4-d] PYRIMIDINES AND THEIR USE AS AGROCHEMICALS
07/07/2011US20110166147 Imidazopyrazine compounds
07/07/2011US20110166131 Substituted pyrrolidine derivative
07/07/2011US20110166123 Novel compositions and methods of use
07/07/2011US20110166119 Synergistic Combinations of Aztreonam with the Carbapenems Meropenem and Ertapenem
07/07/2011US20110166118 New trinem antibiotics and inhibitors of beta-lactamases
07/07/2011US20110166112 Method for stimulating platelet production
07/07/2011US20110166110 Fused Ring Azadecalin Glucocorticoid Receptor Modulators
07/07/2011US20110166108 Methods of use related to xerostomia
07/07/2011US20110166106 Artemisinin and derivatives thereof as antivirals
07/07/2011US20110166103 Boron-containing small molecules
07/07/2011US20110166102 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
07/07/2011US20110166092 Dosing methods for treating disease
07/07/2011US20110166091 Compositions Containing Piperacillin and Tazobactam Useful for Injection
07/07/2011US20110166088 Benzothiazoles and aza-analogues thereof use as antibacterial agents
07/07/2011US20110166087 Pharmaceutical composition for use in treating sexually transmitted infections
07/07/2011US20110166061 Long lasting fusion peptide inhibitors for hiv infection
07/07/2011US20110166058 Organic compositions to treat hsf1-related diseases
07/07/2011US20110165653 Thymidine kinase mutants and fusion proteins having thymidine kinase and guanylate kinase activities
07/07/2011US20110165633 Production of Polyketides and Other Natural Products
07/07/2011US20110165266 Screen for inhibitors of hiv replication